EUVIMEDEUVIMED entdecken
Crossref

Gadolinium (III) oxide nanoparticles coated with folic acid-functionalized poly(β-cyclodextrin-co-pentetic acid) as a biocompatible targeted nano-contrast agent for cancer diagnostic: in vitro and in vivo studies

Tohid Mortezazadeh, Elham Gholibegloo, Nader Riyahi Alam, Sadegh Dehghani, Soheila Haghgoo, Hossein Ghanaati, Mehdi Khoobi

Magnetic Resonance Materials in Physics, Biology and Medicine · 2019-08 · 32 (4) · 487-500

DOI: 10.1007/s10334-019-00738-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Magnetic Resonance Materials in Physics, Biology and Medicine, online erschienen am 07.02.2019. Verfasst von Tohid Mortezazadeh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Physic, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran. Die Arbeit wurde bisher 68-mal zitiert (Crossref) und nennt 56 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: In this study, a novel targeted MRI contrast agent was developed by coating gadolinium oxide nanoparticles (Gd2O3 NPs) with β-cyclodextrin (CD)-based polyester and targeted by folic acid (FA). MATERIALS AND METHODS: The developed Gd2O3@PCD-FA MRI contrast agent was characterized and evaluated in relaxivity, in vitro cell targeting, cell toxicity, blood compatibility and in vivo tumor MR contrast enhancement. RESULTS: In vitro cytotoxicity and hemolysis assays revealed that Gd2O3@PCD-FA NPs have no significant cytotoxicity after 24 and 48 h against normal human breast cell line (MCF-10A) at concentration of up to 50 µg Gd+3/mL and have high blood compatibility at concentration of up to 500 µg Gd+3/mL. In vitro MR imaging experiments showed that Gd2O3@PCD-FA NPs enable targeted contrast T1- and T2-weighted MR imaging of M109 as overexpressing folate receptor cells. Besides, the in vivo analysis indicated that the maximum contrast-to-noise ratio (CNR) of tumor in mice increased after injection of Gd2O3@PCD-FA up to 5.89 ± 1.3 within 1 h under T1-weighted imaging mode and reduced to 1.45 ± 0.44 after 12 h. While CNR increased up to maximum value of 1.98 ± 0.28 after injection of Gd2O3@PCD within 6 h and reduced to 1.12 ± 0.13 within 12 h. CONCLUSION: The results indicate the potential of Gd2O3@PCD-FA to serve as a novel targeted nano-contrast agent in MRI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnimalsCell Line, TumorCoated Materials, BiocompatibleContrast MediaCyclodextrinsDose-Response Relationship, DrugFolic AcidGadoliniumHemolysisHumansMagnetic Resonance ImagingMiceNanoparticlesNeoplasm TransplantationNeoplasmsPentetic AcidThermogravimetry

Stichwörter der Autor:innen

Contrast enhancementLongitudinal relaxivityMagnetic resonance imagingTargeted nano-contrast agent

Substanzen

Coated Materials, BiocompatibleContrast MediaCyclodextrinsgadolinium oxidePentetic AcidFolic AcidGadolinium

Autor:innen und Institutionen

  • Department of Medical Physic, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Biomaterials Group, The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, 1417614411, Tehran, Iran.
  • Department of Medical Physics and Biomedical Engineering, Tehran University of Medical Sciences, Tehran, Iran. mehdi.khoobi@gmail.com.
  • Department of Pharmaceutical Biomaterials, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran. mehdi.khoobi@gmail.com.
  • Department of Medical Physics and Biomedical Engineering, Tehran University of Medical Sciences, Tehran, Iran.
  • Pharmaceutical Department, Food and Drug Laboratory Research Center, Food and Drug Organization (FDO), Ministry of Health, Imam St., Valiasr Cross, Tehran, 1113615911, Iran.

Zitieren

APA

Mortezazadeh, T., Gholibegloo, E., Alam, N. R., Dehghani, S., Haghgoo, S., Ghanaati, H., & Khoobi, M. (2019). Gadolinium (III) oxide nanoparticles coated with folic acid-functionalized poly(β-cyclodextrin-co-pentetic acid) as a biocompatible targeted nano-contrast agent for cancer diagnostic: in vitro and in vivo studies. Magnetic Resonance Materials in Physics, Biology and Medicine, 32(4), 487-500. https://doi.org/10.1007/s10334-019-00738-2

Vancouver

Mortezazadeh T, Gholibegloo E, Alam NR, Dehghani S, Haghgoo S, Ghanaati H, et al. Gadolinium (III) oxide nanoparticles coated with folic acid-functionalized poly(β-cyclodextrin-co-pentetic acid) as a biocompatible targeted nano-contrast agent for cancer diagnostic: in vitro and in vivo studies. Magnetic Resonance Materials in Physics, Biology and Medicine. 2019;32(4):487-500. doi:10.1007/s10334-019-00738-2

BibTeX
@article{Mortezazadeh2019,
  author = {Mortezazadeh, Tohid and Gholibegloo, Elham and Alam, Nader Riyahi and Dehghani, Sadegh and Haghgoo, Soheila and Ghanaati, Hossein and Khoobi, Mehdi},
  title = {Gadolinium (III) oxide nanoparticles coated with folic acid-functionalized poly(β-cyclodextrin-co-pentetic acid) as a biocompatible targeted nano-contrast agent for cancer diagnostic: in vitro and in vivo studies},
  journal = {Magnetic Resonance Materials in Physics, Biology and Medicine},
  year = {2019},
  volume = {32},
  number = {4},
  pages = {487--500},
  doi = {10.1007/s10334-019-00738-2}
}
Kostenlos starten →